2024 State of HIV Stigma Report

Forward by Gilead Sciences

Carmen Villar
Carmen Villar, Vice President, ESG & Corporate Citizenship, Public Affairs, Gilead Sciences

As we reflect on the findings of the 2024 State of HIV Stigma report, it is essential to recognize both the progress we have made and the challenges that lie ahead. At Gilead, our commitment to addressing HIV stigma and advancing health equity is unwavering. Through our work with GLAAD, we strive to ensure that everyone is better informed about HIV. This commitment is not just about improving knowledge; it is about fostering understanding, reducing stigma and creating a more inclusive and supportive society.

The report highlights significant achievements, such as the reduction in the belief that HIV stigma still exists, from 89% in 2020 to 85% in 2024. However, it also underscores areas where our efforts must increase. The stability in general knowledge about HIV across the U.S. and the Southern U.S. is encouraging, but it is concerning that Gen Z continues to be among the least knowledgeable generations about HIV. With only 37% of Gen Z adults feeling knowledgeable about HIV, we must focus on educational initiatives that resonate with younger audiences.

A troubling trend in the report is the decline in the belief that everyone should get tested for HIV, dropping from 77% in 2020 to 67% in 2024. This decline is seen across all regions, signaling a need for renewed advocacy and education efforts. Moreover, the belief that people living with HIV can lead long, healthy lives has also decreased, particularly in the Southern U.S.. These insights remind us that while progress has been made, our work is far from over.

Focusing on Latino/a/e communities and youth is crucial in our fight against HIV stigma. For Latino/a/e communities, tailored outreach and culturally competent education are necessary to address unique challenges and barriers to HIV prevention and treatment. For our youth, innovative and engaging educational programs are vital to increase knowledge and foster a new generation free from stigma.

At Gilead, our commitment extends beyond these findings. We are dedicated to leveraging our resources and expertise to create impactful change. This means supporting community-driven solutions, advocating for policy changes, and ensuring that everyone, regardless of background, has access to accurate information and compassionate care.

The 2024 State of HIV Stigma report serves as a call to action. It challenges us to reflect on our progress and recommit to the work ahead. By focusing on education, representation and community engagement, we can continue to make strides toward a world free from HIV stigma. Together, we can ensure that all individuals, especially the most vulnerable, are informed, supported and empowered.

Sincerely,

Carmen Villar
Vice President, ESG & Corporate Citizenship, Public Affairs, Gilead Sciences

Table of Contents

Share this

View Past Years’ Reports

MEASURE THE MOVEMENT

Your gift allows us to track the impact of our work, helping us better understand the state of awareness and address the gaps of HIV stigma — like pushing for more information out that medications prevent and treat HIV.

Support Our Program

More Publications from GLAAD

The GLAAD Studio Responsibility Index (SRI) maps the quantity, quality and diversity of lesbian, gay, bisexual, transgender, and queer (LGBTQ) people in films released by the seven major motion picture studios during the 2016 calendar year. GLAAD researched films released by 20th Century Fox, Lionsgate Entertainment, Paramount Pictures, Sony Pictures, Universal Pictures, Walt Disney Studios and Warner Brothers, as well as films released by four subsidiaries of these major studios. The report is intended to serve as a road map toward increasing fair, accurate and inclusive LGBTQ representation in film.

Read More

stay tuned!